BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15852272)

  • 1. S100A4 antisense oligodeoxynucleotide suppresses invasive potential of neuroblastoma cells.
    Gao XN; Tang SQ; Zhang XF
    J Pediatr Surg; 2005 Apr; 40(4):648-52. PubMed ID: 15852272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
    Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
    Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9.
    Saleem M; Kweon MH; Johnson JJ; Adhami VM; Elcheva I; Khan N; Bin Hafeez B; Bhat KM; Sarfaraz S; Reagan-Shaw S; Spiegelman VS; Setaluri V; Mukhtar H
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14825-30. PubMed ID: 16990429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
    J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinases and the metastasis-associated gene S100A4 in human neuroblastoma and primitive neuroectodermal tumor cells.
    Bjørnland K; Bratland A ; Rugnes E; Pettersen S; Johansen HT; Aasen AO; Fodstad Ø; Ree AH; Maelandsmo GM
    J Pediatr Surg; 2001 Jul; 36(7):1040-4. PubMed ID: 11431772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.
    Ma X; Yang Y; Wang Y; An G; Lv G
    Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
    Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
    Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation-induced expression of S100A4 increases the invasiveness of laryngeal squamous cell carcinoma.
    Liu J; Guo Y; Fu S; Yang M; Sun KL; Fu WN
    Oncol Rep; 2010 Apr; 23(4):1101-7. PubMed ID: 20204297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.
    Zhang W; Liu Y; Wang CW
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1361-7. PubMed ID: 24867514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression.
    Kohya N; Kitajima Y; Jiao W; Miyazaki K
    Int J Cancer; 2003 Mar; 104(1):44-53. PubMed ID: 12532418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of S100A4 expression enhances invasive and metastatic potentials of COLO16 cutaneous squamous cancer cells.
    Yu LJ; Li Y; Li C; Li H; Wu ML; Liu ZL; Kong QY; Chen XY; Liu XY; An LJ; Liu J
    Cancer Biomark; 2014; 14(5):325-33. PubMed ID: 25171474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of metastasis candidate proteins among HCC cell lines by comparative proteome and biological function analysis of S100A4 in metastasis in vitro.
    Cui JF; Liu YK; Zhang LJ; Shen HL; Song HY; Dai Z; Yu YL; Zhang Y; Sun RX; Chen J; Tang ZY; Yang PY
    Proteomics; 2006 Nov; 6(22):5953-61. PubMed ID: 17051636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancer.
    Stein U; Arlt F; Walther W; Smith J; Waldman T; Harris ED; Mertins SD; Heizmann CW; Allard D; Birchmeier W; Schlag PM; Shoemaker RH
    Gastroenterology; 2006 Nov; 131(5):1486-500. PubMed ID: 17101323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells.
    Takenaga K; Nakamura Y; Sakiyama S
    Oncogene; 1997 Jan; 14(3):331-7. PubMed ID: 9018119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of metastasis-associated S100A4 gene expression by gamma-interferon in human colon adenocarcinoma cells.
    Takenaga K
    Br J Cancer; 1999 Apr; 80(1-2):127-32. PubMed ID: 10389988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interaction between Smad3 and S100A4 (metastatin-1) for TGF-beta-mediated cancer cell invasiveness.
    Matsuura I; Lai CY; Chiang KN
    Biochem J; 2010 Feb; 426(3):327-35. PubMed ID: 20070253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.